BIBW 2992 (Afatinib) and Vinorelbine

Stopped The recruitment was discontinued because of failure to meet expected enrolment goals

Conditions

• Carcinoma Breast Stage IV

Interventions

• DRUG: BIBW 2992 in combination with vinorelbine

Sponsor

University of Magdeburg

Collaborators

• [object Object]